Key facts
- This page summarizes Diane E. Wilfong's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Sep 2025, 19:34.
Diane E. Wilfong - 10 Sep 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- Interim Corp Controller & CAO
- Issuer ticker
- GILD
- Reported as of
- 10 Sep 2025
- Net transaction value
- -$38,954
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2025, 19:34:04 UTC
- Prior SEC filing
- 11 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Diane E. Wilfong filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 11 Sep 2025.
Change
- Previous filing in this sequence was filed on 11 Jun 2025.
- Current net transaction value: -$38,954.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001374988
Primary reporting owner
Wilfong Diane E.
- Relationship
- Interim Corp Controller & CAO
- Address
- GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- /s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
- Signature date
- 11 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +921
- Change %
- +2%
- Price
- Shares after
- 46,597
- Date
- 10 Sep 2025
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Tax liability
- Transaction value
- $38,954
- Shares
- -338
- Change %
- -0.73%
- Price
- $115.25
- Shares after
- 46,259
- Date
- 10 Sep 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -921
- Change %
- -10%
- Price
- Shares after
- 7,864
- Date
- 10 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 921
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.